We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Aug 2019 to Aug 2024
China's commerce ministry said late Monday it imposed conditions on U.S. automaker General Motors Co.'s plan to buy part of Delphi Corp. (DPHIQ), because of concerns the deal may have a negative impact on competition in the domestic auto market.
The ministry said it was also concerned the deal will harm competition in the local auto parts market.
The ministry said that under the conditions it imposed on the deal, GM won't be allowed to set procurement conditions that benefit Delphi only.
Delphi, GM's former parts division, has relied heavily on its former parent company as it has navigated bankruptcy proceedings.
Delphi won approvals from U.S courts and the European Commission in August to sell assets to its lenders and General Motors.
-JR Wu and Juan Chen contributed to this story; Dow Jones Newswires; 8610 6588 5848; juan.chen@dowjones.com
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
